Indian Pharma Industry Under Scrutiny: Join Eminence Group’s Pledge to Uphold Quality!In the wake of recent revelations, the Indian pharma industry—a cornerstone of global healthcare—finds itself facing a critical juncture. The August 2024 drug alert report from the CDSCO has flagged 53 widely-used medications, including Paracetamol and Pan-D, as "Not of Standard Quality" (NSQ). This…